XML 49 R37.htm IDEA: XBRL DOCUMENT
v3.23.1

List of principal subsidiaries | 12 Months Ended
--- | ---
Dec. 31, 2022
Disclosure of subsidiaries [abstract] |
List of principal subsidiaries |
3 2 | List of subsidiaries
See accounting policy in note 36(A)(ii). The following list contains the material subsidiaries of the Group at December 31, 2022 and December 31, 2021 are as follows:
Name of subsidiaries |  | Place of incorporation/ operation |  | Issued and fully paid share capital |  | Proportion of nominal value of issue capital held by the Company |  |  | Principal activities
|  |  |  |  |  | 2022 |  |  | 2021 |  |  |
|  |  |  |  |  | Directly |  |  | Indirectly |  |  | Directly |  |  | Indirectly |  |  |
|  |  |  |  |  | % |  |  | % |  |  | % |  |  | % |  |  |
Prenetics Limited |  | Hong Kong |  | HK$415,276,716 |  |  | — |  |  |  | 100 |  |  |  | — |  |  |  | 100 |  |  | Genetic and diagnostic health testing
Prenetics EMEA Limited |  | United Kingdom |  | GBP76,765.81 |  |  | — |  |  |  | 100 |  |  |  | — |  |  |  | 100 |  |  | Genetic and diagnostic health testing
ACT Genomics Holdings Company Limited (note 33) |  | Cayman Islands |  | $16,713 |  |  | 74.39 |  |  |  | — |  |  |  | — |  |  |  | — |  |  | Precise cancer genetic testing services
ACT Genomics Co., Ltd. |  | Taiwan |  | TWD455,080,000 |  |  | — |  |  |  | 74.33 |  |  |  | — |  |  |  | — |  |  | Precise cancer genetic testing - services
ACT Genomics (Hong Kong) Limited |  | Hong Kong |  | HK$775,000 |  |  | — |  |  |  | 74.39 |  |  |  | — |  |  |  | — |  |  | Precise cancer genetic testing - services
Sanomics Limited |  | Hong Kong |  | HK$500,000 |  |  | — |  |  |  | 74.39 |  |  |  | — |  |  |  | — |  |  | Precise cancer genetic testing - services
MC Diagnostics Limited |  | United Kingdom |  | GBP1,164 |  |  | — |  |  |  | 74.39 |  |  |  | — |  |  |  | — |  |  | Sales of medical diagnostics products

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of subsidiaries. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 17 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 16 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard -URIDate 2022-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph B4 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration